EGFR and urothelial carcinoma: This was in line with Eriksson et al. [10] who analyzed a cohort of 599 cases of urothelial carcinoma previously categorized to molecular subtypes for EGFR gene expression and genomic alterations and concluded that increased EGFR mRNA and protein levels were largely confined to the basal subtype [49].